Papers

3

Total Citations

30

H-Index

3

About

Dr. Mark Sidhom is a leading researcher in prostate cancer treatment decision-making, focusing on the critical juncture where men with localised prostate cancer must choose between robotic prostatectomy and radiotherapy. His work addresses a highly preference-sensitive decision, where treatments offer comparable cure rates but vastly different side effect profiles. Dr. Sidhom’s major contributions include pioneering the use of combined clinics to support patients through this difficult choice, demonstrating that such an approach leads to low conflict and high satisfaction among patients. His most cited work, a qualitative study on decision support needs (21 citations), reveals the deep informational and emotional challenges men face when weighing these options. Dr. Sidhom also authored the foundational PREPaRE study protocol, which established a mixed-methods framework to systematically investigate treatment decision-making. Through his research, he has illuminated the specific needs of patients navigating this preference-sensitive choice, directly informing clinical practice and the development of decision aids. His work is essential for clinicians seeking to provide truly patient-centred care in early-stage prostate cancer.

Research Focus

Key Achievements

3
H-Index
3
Papers
30
Total Citations
10
Avg Citations/Paper
🏆 Most Cited Paper
Robot or radiation? A qualitative study of the decision support needs of men with localised prostate cancer choosing between robotic prostatectomy and radiotherapy treatment
21 citations · 2019
📈 Most Prolific Year: 2019 (1 Papers)
🤝 Key Collaborators: 10
🏛 Institutions: UNSW Sydney, South Western Sydney Local Health District, Liverpool Hospital

Top Papers

  1. 1
  2. 2
  3. 3

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago